MFDS — authorised 27 August 2018
- Marketing authorisation holder: TETRAPHASE PHARMS
- Status: likely_approved
🇰🇷 Xerava in South Korea
MFDS authorised Xerava on 27 August 2018
Marketing authorisation
Xerava in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Xerava approved in South Korea?
Yes. MFDS authorised it on 27 August 2018.
Who is the marketing authorisation holder for Xerava in South Korea?
TETRAPHASE PHARMS holds the South Korean marketing authorisation.